The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against COVID-19. In a new study, researchers provide further proof of this by showing that mumps IgG titers, or levels of IgG antibody, are inversely correlated with severity in recovered COVID-19 patients previously vaccinated with the MMR II vaccine.